Fidelity
Home > Boards > US Listed > Medical - Drugs > Supernus Pharmaceuticals (SUPN)

1:21AM Supernus Pharma prices 10 mln share IP0

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 425
Posts 21,160
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/1/2014 5:24:36 PM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 4/1/2014 5:19:11 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 3/26/2014 5:19:35 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/21/2014 4:49:00 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 3/18/2014 11:01:14 AM
Supernus Announces Fourth Quarter and Full Year 2013 Results "GlobeNewswire Inc." - 3/12/2014 4:30:00 PM
Supernus Announces Issuance of Third US Patent Protecting Trokendi XR™ "Business Wire" - 3/12/2014 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/26/2014 4:16:32 PM
Supernus to Host Fourth Quarter and Full Year 2013 Earnings Conference Call "Business Wire" - 2/25/2014 7:30:00 AM
Supernus to Present at Cowen and Company Healthcare Conference in March "Business Wire" - 2/20/2014 7:30:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/14/2014 8:16:11 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/13/2014 3:38:29 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/10/2014 4:10:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/7/2014 4:16:23 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/7/2014 3:48:06 PM
Supernus at Citibank and RBC Global Healthcare Conferences in February "Business Wire" - 2/7/2014 7:30:00 AM
Supernus Announces Publication of Phase III Study (PROSPER) Results on Oxtellar XR® "Business Wire" - 2/3/2014 7:30:00 AM
Supernus Announces Issuance of First Use Patents Protecting SPN-812 as a Novel Non-Stimulant ADHD Product "GlobeNewswire Inc." - 1/27/2014 9:00:00 AM
Supernus Announces Issuance of Third US Patent Protecting Oxtellar XR(R) "GlobeNewswire Inc." - 1/7/2014 9:00:00 AM
Bear of the Day: Magellan Health Services (MGLN) - Bear of the Day "Zacks" - 12/30/2013 4:16:01 AM
surf1944   Tuesday, 05/01/12 08:26:57 AM
Re: None
Post # of 104 
1:21AM Supernus Pharma prices 10 mln share IP0 at $5.00 per share, price in-line with expectations (SUPN) :

Supernus Pharmaceuticals (SUPN), a former Shire sub developing improved drug formulations for epilepsy and ADHD, plans to raise $55 million by offering 11.0 million shares at a price of $5.00. Supernus Pharmaceuticals will command a market value of $125 million. The Rockville, MD-based company, which was founded in 2005, plans to list on the NASDAQ under the symbol SUPN. Citi and Piper Jaffray (PJC) are the joint bookrunners on the deal.

http://seekingalpha.com/article/544941-6-ipos-planned-for-this-week?source=yahoo


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist